Compositions comprising antibodies targeting factor P

US9988440B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Leslie Ngozi Anuna Johnson · Revere, US
• Ute Jaeger · Munich, DE
• Yong-In Kim · Westborough, US
• Christian Carsten Silvester KUNZ · Munich, DE
• Igor Splawski · Winchester, US
• Michael Roguska · Cambridge, US
• Joy Ghosh · Boston, US
• Barbara Brannetti · Basel, CH
• Michael Stefanidakis · Brookline, US
• Sha LIAO · Lexington, US

Key dates

• Filing date: Jun 19, 2014
• Grant date: Jun 5, 2018
• Expiry date: Jun 19, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to antibodies or antigen binding fragments thereof that bind to complement Factor P and used thereof as well as combinations of anti-Factor P antibodies with antibodies or antigen binding fragments thereof that bind to complement component 5 (C5).